ArticleTranslational lung cancer research2025
Utility of ctDNA-molecular residual disease in predicting minimal residual disease in non-small cell lung cancer patients after radical resection.
Katsuhiro Masago et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.